NOAEL Studies
Cosmetic Ingredient
2,7-Naphthalenediol NOAEL Studies
INCI: 2,7-NAPHTHALENEDIOL
CAS: 582-17-2
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 195 | mg/kg bw/day | rat | oral | 5-19 Gestation day | Developmental | SCCS; Patel, M.V. Prenatal developmental toxicity study of A 019 in rats. Jai Research Foundation, Valvada, India, internal study code: 4745. Archive code at Henkel KGaA, Düsseldorf, Report No. R 0500011 |
| COSMOS DB | NOAEL | 65 | mg/kg bw/day | rat | oral | 5-19 Gestation day | Developmental | SCCS; Patel, M.V. Prenatal developmental toxicity study of A 019 in rats. Jai Research Foundation, Valvada, India, internal study code: 4745. Archive code at Henkel KGaA, Düsseldorf, Report No. R 0500011 |
SCCS Opinion 7 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =60 | mg/kg/day | rat | oral | 5 weeks | NOAEL study | p.15 |
| SCCS Opinion | NOAEL | =70 | mg/kg bw/day | rat | - | 90 days | NOAEL study | p.16 |
| SCCS Opinion | NOAEL | =65 | mg/kg bw/day | human | - | - | NOAEL study | p.22 |
| SCCS Opinion | NOAEL | =585 | mg/kg bw/day | human | - | - | NOAEL study | p.22 |
| SCCS Opinion | NOAEL | =0.06 | mg/kg bw/d | rat | oral | - | dermal absorption | p.22 |
| SCCS Opinion | NOAEL | =65 | mg/kg bw/d | rat | oral | - | dermal absorption | p.22 |
| SCCS Opinion | NOAEL | =0.04 | mg/kg bw/d | rat | oral | - | dermal absorption | p.22 |
Regulatory source 16 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 60 | mg/kg/day | rat | oral | 5 weeks | - | p.15 |
| Regulatory source | - | 70 | mg/kg bw/day | rat | - | 90 days | - | p.16 |
| Regulatory source | - | 60 | mg/kg | rat | oral | 11 week | - | p.21 |
| Regulatory source | - | 65 | mg/kg bw/day | human | - | - | - | p.22 |
| Regulatory source | - | 585 | mg/kg bw/day | human | - | - | - | p.22 |
| Regulatory source | - | 60 | mg/kg bw/day | rat | oral | 5 weeks | - | p.14 |
| Regulatory source | - | 60 | mg/kg bw | rat | oral | 11 week | - | p.20 |
| Regulatory source | dermal absorption | 70 | mg/kg bw/day | rat | dermal | 90 day | dermal absorption | p.23 |
| Regulatory source | dermal absorption | 65 | mg/kg bw/day | rat | dermal | 90 day | dermal absorption | p.23 |
| Regulatory source | dermal absorption | =0.06 | mg/kg bw/d | rat | oral | - | dermal absorption | p.22 |
| Regulatory source | dermal absorption | =65 | mg/kg bw/d | rat | oral | - | dermal absorption | p.22 |
| Regulatory source | dermal absorption | =0.04 | mg/kg bw/d | rat | oral | - | dermal absorption | p.22 |
| Regulatory source | irritation | 70 | mg/kg bw/day | rat | oral | 90 day | irritation | p.23 |
| Regulatory source | irritation | 70 | mg/kg bw/day | rat | dermal | 90 day | irritation | p.23 |
| Regulatory source | irritation | 70 | mg/kg bw/day | rat | - | 90 day | irritation | p.22 |
| Regulatory source | irritation | 65 | mg/kg bw/day | rat | - | 90 day | irritation | p.22 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 0TO8E448UD | UNII | - | - | - | chemical | - |